8-37965350-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000025.3(ADRB3):c.1120G>A(p.Ala374Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000447 in 1,542,518 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000025.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADRB3 | ENST00000345060.5 | c.1120G>A | p.Ala374Thr | missense_variant | 1/2 | 1 | NM_000025.3 | ENSP00000343782.3 | ||
ENSG00000285880 | ENST00000647937.1 | c.604G>A | p.Ala202Thr | missense_variant | 1/2 | ENSP00000497740.1 | ||||
ADRB3 | ENST00000520341.2 | n.1248G>A | non_coding_transcript_exon_variant | 1/1 | 6 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152170Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000183 AC: 25AN: 136308Hom.: 0 AF XY: 0.000189 AC XY: 14AN XY: 74234
GnomAD4 exome AF: 0.0000360 AC: 50AN: 1390232Hom.: 0 Cov.: 31 AF XY: 0.0000336 AC XY: 23AN XY: 685540
GnomAD4 genome AF: 0.000125 AC: 19AN: 152286Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 06, 2023 | The c.1120G>A (p.A374T) alteration is located in exon 1 (coding exon 1) of the ADRB3 gene. This alteration results from a G to A substitution at nucleotide position 1120, causing the alanine (A) at amino acid position 374 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at